The FDA has issued recent updates on several drugs that are currently in shortage or have been discontinued:
- Amino Acids (Updated – Currently in Shortage)
- Aminocaproic Acid Injection, USP (Updated – Currently in Shortage)
- Asparaginase Erwinia Chrysanthemi (Erwinaze) (Updated – Currently in Shortage)
- Atropine Sulfate Injection (Updated – Currently in Shortage)
- Bromocriptine Mesylate Tablets (New – Discontinuation)
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Calcium Chloride Injection, USP (Updated – Currently in Shortage)
- Capromab Pendetide (ProstaScint) Injection (New – Discontinuation)
- Dextrose 50% Injection (Updated – Currently in Shortage)
- Dobutamine Hydrochloride Injection (Updated – Currently in Shortage)
- Doxycycline Hyclate Capsules (New – Discontinuation)
- Epinephrine Injection, Auto-Injector (Updated – Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated – Currently in Shortage)
- Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution (Updated – Currently in Shortage)
- Heparin Sodium and Sodium Chloride 0.9% Injection (Updated – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Ketamine Injection (Updated – Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated – Currently in Shortage)
- Labetalol Hydrochloride Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated – Currently in Shortage)
- Lorazepam Injection, USP (Updated – Currently in Shortage)
- Magnesium Sulfate Injection (Updated – Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated – Currently in Shortage)
- Omeprazole Capsules (New – Discontinuation)
- Ondansetron Hydrochloride Injection (Updated – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Risedronate Sodium Tablets (New – Discontinuation)
- Ropivacaine Hydrochloride Injection (Updated – Currently in Shortage)
- Sodium Acetate Injection, USP (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated – Currently in Shortage)
- Sodium Chloride Injection USP, 0.9% Vials (Updated – Currently in Shortage)
- Sterile Water (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
